UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 338.

A

Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; Purdy, G; ... Machin, SJ; + view all (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Ala, A; Standish, R; Khan, K; Hillan, K; Dhillon, A; Hodgson, H; (2002) Podoplanin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) localisation in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Journal of Hepatology , 36 501-.

Ala, A; Standish, R; Khan, K; Stubbs, M; Hillan, K; Dhillon, AP; Hodgson, HJF; (2002) Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and podoplanin localisation in primary sclerosing cholangitis (PSC) & primary biliary cirrhosis (PBC). Gut , 50 202-.

Allcock, RJN; Atrazhev, AM; Beck, S; de Jong, PJ; Elliott, JF; Forbes, S; Halls, K; ... Williams, S; + view all (2002) The MHC haplotype project: A resource for HLA-linked association studies. TISSUE ANTIGENS , 59 (6) 520 - 521.

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Waud, WR; Hartley, JA; Howard, PW; Gregson, SJ; ... Sausville, EA; + view all (2002) Efficacy evaluations of SJG-136 (NSC 694501), a novel pyrrolobenzodiazepine dimer with broad spectrum antitumor activity. In: (pp. 315-).

Ameer-Beg, SM; Barber, PR; Hodgkiss, RJ; Locke, RJ; Newman, RG; Tozer, GM; Vojnovic, B; (2002) Application of multiphoton steady state and lifetime imaging to mapping of tumour vascular architecture in vivo. In: (pp. pp. 85-95).

Ancliff, PJ; Gale, RE; Somerville, TC; Kwaja, A; Liesner, R; Hann, IM; Linch, DC; (2002) Complete inhibition of neutrophil elastase fails to correct the in vitro phenotype of severe congenital neutropenia. In: BLOOD. (pp. 243A - 243A). AMER SOC HEMATOLOGY

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood , 100 (2) pp. 707-709. 10.1182/blood-2002-01-0060. Green open access
file

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Angeli, I; James, C; Morgan, P; Sharpe, P; (2002) Misexpression of Genes in Mouse Tooth Germs Using In Vitro Electroporation. Connective Tissue Research , 43 (2) pp. 180-185. 10.1080/713713525.

Angeli, I; James, CT; Morgan, PJ; Sharpe, PT; (2002) Misexpression of genes in mouse tooth germs using in vitro electroporation. CONNECTIVE TISSUE RESEARCH , 43 (2-3) pp. 180-185. 10.1080/03008200290000943.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; ... Fielding, A; + view all (2002) Inhibition of survivin expression suppresses the growth of transformed large cell non-Hodgkin lymphoma. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 352A-352A). AMER SOC HEMATOLOGY

Ardeshna, K; Smith, P; Norton, A; Hancock, B; Hoskin, PJ; (2002) The long term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkin's lymphoma: results of a British National Lymphoma randomized trial. In: (pp. 76-).

Ardeshna, KM; Pizzey, AR; Walker, SJ; Devereux, S; Khwaja, A; (2002) The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3 beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. BRIT J HAEMATOL , 119 (3) 826 - 829.

Arkenau, HT; Widjaja, A; (2002) An unusual case of cholestasis and makrohematuria in a 52-year-old patient. Medizinische Klinik , 97 (8) pp. 480-483. 10.1007/s00063-002-1183-3.

Asher, D; Atterbury, C; Chapman, C; Cohen, H; Jones, H; Love, E; (2002) The 2000/2001 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Batter, V; Coleman, R; Piccart, M; ... Cofer, T; + view all (2002) Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. Breast Cancer Research and Treatment , 76 138-.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; Isaacson, PG; (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. LABORATORY INVESTIGATION , 82 (1) 229A-230A.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; Isaacson, PG; (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. MODERN PATHOLOGY , 15 (1) 229A-230A.

Avivi, I; Bacon, CM; Obermann, EC; Quian, WD; Smith, P; Linch, DC; Dogan, A; (2002) Histological and clinical prognostic factors in follicular lymphoma: Proposal for a prognostic model. In: BLOOD. (pp. 37A - 37A). AMER SOC HEMATOLOGY

B

Barnouin, K; Dubuisson, ML; Child, ES; Fernandez de Mattos, S; Glassford, J; Medema, RH; Mann, DJ; (2002) H202 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. Journal of Biological Chemistry , 277 (16) pp. 13761-13770. Gold open access

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Bengala, C; Guarneri, V; Ledermann, J; Wandt, H; Lotz, J; Cure, J; Rosti, G; ... Conte, P; + view all (2002) High-dose chemotherapy (HDC) with autologous hemopoeitic support for advanced ovarian cancer in 1st complete remission: retrospective analysis from Solid Tumor Registry of the European Group for Blood and Marrow Transplantation. In: (pp. S32-S32). NATURE PUBLISHING GROUP

Bentzen, SM; Saunders, MI; Dische, S; (2002) From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome. Clinical Oncology , 14 (5) pp. 372-381.

Bernassola, F; Salomoni, P; Di Como, C; Pagano, N; Melino, G; Pandolfi, PP; (2002) PML enhances p73 transcriptional activity and biological functions by preventing its proteasome-dependent degradation. In: BLOOD. (pp. 177B - 177B). AMER SOC HEMATOLOGY

Bernstein, H-G; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; Diekmann, S; ... Baumann, B; + view all (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 pp. 91-93.

Boddy, AV; Todd, R; Verrill, M; Sludden, J; Fishwick, K; Robson, L; Cassidy, J; ... Calvert, AH; + view all (2002) Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study. European Journal of Cancer , 38 98-.

Bogunia-Kubik, K; Natarajan, P; Madrigal, JA; Cohen, SBA; (2002) The effect of cord blood sera on CD69 expression. IMMUNOL LETT , 84 (1) pp. 77-80.

Bomanji, JB; Syed, R; Brock, C; Jankowska, P; Dogan, A; Costa, DC; Ell, PJ; (2002) Case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease. Journal of Clinical Oncology , 20 (15) pp. 3347-3349.

Boshoff, C; (2002) Kaposi's sarcoma biology. IUBMB Life , 53 (4-5) pp. 259-261. 10.1080/15216540212645.

Bowen, RL; Francis, RJ; Green, AJ; Baig, S; Knell, V; Buscombe, JR; Hilson, AJW; (2002) How accurately can the oncologist report FDG-PET tumour response using the ADAC vertex plus dual-headed gamma camera? British Journal of Cancer , 86 S102-S102.

Bowen, RL; Francis, RJ; Green, AJ; Baig, S; Knell, V; Buscombe, JR; Hilson, AJW; (2002) How accurately can the oncologist report FDG-PET tumour response using the ADAC vertex plus dual-headed gamma camera? BRIT J CANCER , 86 S102 - S102.

Braybrooke, JP; Slade, A; Gibson, R; Deplanque, G; Madhusudan, S; Makris, A; (2002) Phase one study of MetXia-P450 gene therapy for patients with advanced breast cancer or melanoma. In: (pp. 22a-).

Brett, BT; Smith, SC; Bouvier, CV; Michaeli, D; Hochhauser, D; Davidson, BR; Kurzawinski, TR; ... Caplin, ME; + view all (2002) Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. Journal of Clinical Oncology , 20 (20) pp. 4225-4231. 10.1200/JCO.2002.11.151.

Brown, RS; Edwards, J; Bartlett, JW; Jones, C; Dogan, A; (2002) Routine acid decalcification of bone marrow samples can preserve DNA for FISH and CGH studies in metastatic prostate cancer. Journal of Histochemistry and Cytochemistry , 50 pp. 113-115.

Bunn, PA; Calvert, H; (2002) Pemetrexed, a novel multitargeted antifolate: Current development and future directions - Introduction. SEMIN ONCOL , 29 (2) 1 - 2. 10.1053/sonc.2002.30757.

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emmott, J; Wong, WL; (2002) Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [F-18]- fluorodeoxyglucose positron emission tomography. European Journal of Cancer , 38 (3) pp. 375-379.

Burcombe, RJ; Makris, A; Wilson, GD; (2002) Evaluation of topoisomerase II-alpha as a predictor of clinical and pathological response to neoadjuvant chemotherapy in operable breast cancer. In: (pp. 447a-).

Burger, AM; Fiebig, HH; Hagan, DR; Tiberghien, A; Howard, PW; Schultz, R; Hartley, JA; (2002) The monomer pyrrolobenzodiazepine (PBD) DNA minor-groove binding agent DRH-417 (NSC 709119) shows pre-clinical activity in human renal cell carcinoma. In: (pp. 5719-).

Burk, K; (2002) Thirst for Knowledge. Prospect (8/2002) pp. 40-43.

C

Calvert, H; Bunn, PA; (2002) Future directions in the development of pemetrexed. SEMINARS IN ONCOLOGY , 29 (2) 54 - 61. 10.1053/sonc.2002.30761.

Carr, WH; Little, AM; Mocarski, E; Parham, P; (2002) NK-cell mediated lysis of autologous HCMV infected skin fibroblasts is highly variable among NK cell cloes and polyclonal NK-cell lines. Clinical Immunology , 105 pp. 126-140.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; Skelton, L; ... Begent, RHJ; + view all (2002) Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br J Cancer , 86 (9) pp. 1401-1410. 10.1038/sj.bjc.6600198.

Chatterjee, R; KOTTARIDIS, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplantation (607) 610-.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) pp. 607-610. 10.1038/sj.bmt.1703421.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Chow, E; Coia, L; Wu, J; Nanjan, N; Kirkbride, P; Hoskin, PJ; (2002) Debate: this house believes that multiple-fraction radiotherapy is a barrier to referral for palliative radiotherapy for bone metastases. Current Oncology , 9 pp. 60-66.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiotherapy And Oncology , 64 (3) pp. 275-280.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. International Journal of Cancer p. 7.

Cohen, H; (2002) Where do we go from here? [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Love, E; Todd, A; Soldan, K; Jones, H; Williamson, LM; (2002) 5 years of serious hazards of transfusion (SHOT): powerful data, slow progress in implementing recommendations. In: (Proceedings) British society for haematology annual scientific meeting.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 32 (11) pp. 3246-3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Colombari, R; Togni, R; Furlanetto, A; Quaglia, A; Dhillon, A; Demichelis, F; Spinoso, A; ... Dhillon, AP; + view all (2002) Royal free (RFH) scoring system for unifocal hepatocellular carcinoma (HCC) < 5 cm diameter: A valuable prognostic tool. J HEPATOL , 36 78 - 78.

Conde, L; Mateos, A; Herrero, J; Dopazo, J; (2002) Unsupervised reduction of the dimensionality followed by supervised learning with a perceptron improves the classification of conditions in DNA microarray gene expression data. In: Bourlard, H and Adali, T and Bengio, S and Larsen, J and Douglas, S, (eds.) (Proceedings) 12th IEEE Workshop on Neural Networks for Signal Processing. (pp. pp. 77-86). IEEE

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Bioconjug Chem , 13 (1) pp. 7-15.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain fv :: tumor necrosis factor-alpha fusion protein (vol 13, pg 7, 2002). BIOCONJUGATE CHEM , 13 (2) 385 - 385. 10.1021/bc020015h.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. Bioconjugate Chemistry , 13 (1) pp. 7-15. 10.1021/bc000178a.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. BIOCONJUGATE CHEM , 13 (1) 7 - 15. 10.1021/bc000178a.

Corell, A; Cox, ST; Soteriou, B; Ramon, D; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*14011,*1402,*1403 and*1404 alleles. TISSUE ANTIGENS , 59 (1) pp. 66-69. 10.1034/j.1399-0039.2002.590116.x.

Corell, A; Little, AM; Marsh, SGE; Madrigal, JA; (2002) HLA matching in unrelated stem cell transplantation: what to type for? Inmunologia , 21: pp. 169-177.

Corrie, P; Mayer, A; Shaw, J; D'Ath, S; Blagden, S; Blesing, C; Price, P; (2002) Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients. BRITISH JOURNAL OF CANCER , 87 (7) pp. 716-719. 10.1038/sj.bjc.6600523.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Craddock, C; Hochhauser, D; (2002) Realising the potential of targeted therapies in oncology. LANCET , 360 (9331) 424 - 425.

Craig, CE; Gallen, IWPFROIWPO; (2002) Possible functional regression of insulinoma with prolonged octreotide. Possible functional regression of insulinoma with prolonged octreotide.

D

Davidoff, AM; Nathwani, AC; Spurbeck, WW; Ng, CYC; Zhou, J; Vanin, EF; (2002) rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res , 62 (11) pp. 3077-3083.

Delenda, C; Audit, M; Danos, O; (2002) Biosafety issues in lentivector production. Curr Top Microbiol Immunol , 261 pp. 123-141.

Diatloff-Zito, C; Marquis, E; Nicole, A; Labit, H; Junien, C; Robert, JJ; (2002) Altered DNA methylation pattern in the transient neonatal diabetes determined by the genomic sequencing method. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 175 - 175). UNIV CHICAGO PRESS

Diss, TC; Liu, HX; Du, MQ; Isaacson, PG; (2002) Improvements to B-cell clonality analysis using PCR amplification of immunoglobin light chain genes. Molecular Pathology , 55 (2) pp. 98-101.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Dogan, A; Isaacson, PG; (2002) Lymphomas in the gut: a practical approach. CPD Bulletin , 4 pp. 18-24.

Du, MQ; Isaacson, PG; (2002) Gastric MALT lymphoma: from aetiology to treatment. The Lancet Oncology , 3 pp. 97-104.

Duarte, R.F.; Chen, F.E.; Lowdell, M.W.; Potter, M.N.; Lamana, M.L.; Prentice, H.G.; Madrigal, J.A.; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; Prentice, HG; (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 p. 66.

Dunn, PPJ; Cox, ST; Little, AM; (2002) Sequencing protocols for detectio of HLA class I polymorphism. In: Powis, SH and Vaughan, RW, (eds.) Methods in Molecular Biology. (pp. 191-222). Humana Press Inc: Totowa.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; ... Madrigal, JA; + view all (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. TISSUE ANTIGENS , 59 (6) pp. 522-524. 10.1034/j.1399-0039.2002.590610.x.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; ... Madrigal, JA; + view all (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens , 59 (6) pp. 522-524.

E

El Emir, E; Petrie, IA; Boxer, GM; Boden, R; Dearling, JLJ; Raleigh, JA; Mantavani, A; ... Pedley, RB; + view all (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. British Journal of Cancer , 86 S112-S112.

El-Emir, E; Petrie, ; I, A; Boxer, ; G, M; Boden, ; R, ; ... R, HJAPRB; + view all (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 257-).

El-Emir, E; Petrie, IA; Boxer, GM; Boden, R; Dearling, JLJ; Raleigh, JA; Mantavani, A; ... Pedley, RB; + view all (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. BRIT J CANCER , 86 S112 - S112.

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; Reid, WMN; Davidson, T; MacLean, AB; (2002) The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. ANTICANCER RESEARCH , 22 (2A) 857 - 861.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; ... Sarno, S; + view all (2002) Transcriptional programming in haematopoietic stem cells. EXPERIMENTAL HEMATOLOGY , 30 (6) p. 37.

Enver, T; Brown, J; Bruno, L; Gupta, R; Heyworth, C; Hoffmann, R; Joshi, C; ... Seidl, T; + view all (2002) Dynamic analysis of stem cell self renewal and differentiation using global gene expression profiling. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 721A-721A). AMER SOC HEMATOLOGY

Ezoe, S; Matsumura, I; Shibayama, H; Satoh, Y; Enver, T; Kanakura, Y; (2002) GATA-1 and GATA-2 inhibit cytokine-dependent growth of hematopoietic cells through the inhibition of MAPK activities. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 522A-523A). AMER SOC HEMATOLOGY

F

Fielding, A; (2002) Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France. Expert Rev Vaccines , 1 (2) pp. 131-133. 10.1586/14760584.1.2.131.

Fielding, A; Grote, D; Cattaneo, R; (2002) The anti-lymphoma efficacy of replicating, attenuated measles virus is enhanced by viral expression of GM-CSF. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 578A-578A). AMER SOC HEMATOLOGY

Firat, H; Cochet, M; Rohrlich, P-S; Garcia-Pons, F; Darche, S; Danos, O; Lemonnier, FA; (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol , 14 (8) pp. 925-934.

Firat, H; Zennou, V; Garcia-Pons, F; Ginhoux, F; Cochet, M; Danos, O; Lemonnier, FA; ... Charneau, P; + view all (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med , 4 (1) pp. 38-45.

Flanagan, AM; Massey, HM; Wilson, C; Vellodi, A; Horton, MA; Steward, CG; (2002) Macrophage colony-stimulating factor and rand ligand NF-kB. Bone , 30 pp. 85-90.

Flanagan, AM; Massey, HM; Wilson, C; Vellodi, A; Horton, MA; Steward, CG; (2002) Macrophage colony-stimulating factor and receptor activator NF-kappa B ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro. BONE , 30 (1) 85 - 90.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 SUPPL.) pp. 1249-1257.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 Suppl) pp. 1249-1257.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Dearling, J; Boden, RABRHJ; (2002) Antibody and radionuclide characteristics can enhance the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. International Journal of Radiation Biology , 78 pp. 407-415.

Ford, HER; Mitchell, F; Cunningham, D; Farrugia, DC; Hill, ME; Rees, C; Calvert, AH; ... Jackman, AL; + view all (2002) Patterns of elevation of plasma 2 '-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. CLIN CANCER RES , 8 (1) 103 - 109.

Fordham-Skelton, AP; Chilley, P; Lumbreras, V; Reignoux, S; Fenton, TR; Dahm, CC; Pages, M; (2002) A novel higher plant protein tyrosine phosphatase interacts with SNF1-related protein kinases via a KIS (kinase interaction sequence) domain. Plant J , 29 (6) pp. 705-715.

Foroni, L; Hoffbrand, AV; (2002) Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY , 15 (1) pp. 71-90. 10.1053/beha.2002.0186.

Foroni, L; Mortuza, YF; Hoffbrand, AV; (2002) Molecular investigation of minimal residual disease in adult acute lymphoblastic leukemia of B lineage. In: Zipf, TF and Johnson, DA, (eds.) Leukemia and Lymphoma: detection of minimal residual disease. (pp. 97-118). Human Press Inc: Totowa.

Forster, MD; Braybrooke, J; Madhusudan, S; Kaur, K; Hoare, S; Balkwill, F; Ganesan, TS; ... Harris, AL; + view all (2002) A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancer. In: (pp. S38-S38). NATURE PUBLISHING GROUP

Francis, RJ; Green, AJ; Baig, S; Knell, V; Frisken, I; Bowen, RL; Hilson, AJW; ... Begent, RHJ; + view all (2002) A novel approach to assessing response to chemotherapy using hybrid camera FDG PET. British Journal of Cancer , 86 S100-S100.

Francis, RJ; Green, AJ; Baig, S; Knell, V; Frisken, I; Bowen, RL; Hilson, AJW; ... Begent, RHJ; + view all (2002) A novel approach to assessing response to chemotherapy using hybrid camera FDG PET. BRIT J CANCER , 86 S100 - S100.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; Martin, J; ... Begent, RHJ; + view all (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 87 (6) pp. 600-607. 10.1038/sj.bjc.6600517.

Freeman, A; Treurnicht, K; Munson, P; Miller, K; Parkinson, MC; (2002) A comparison of basal cell markers used in the prostate. HISTOPATHOLOGY , 40 (5) pp. 492-494. 10.1046/j.1365-2559.2002.t01-6-01390.x.

G

GUPTA, R; Bain, BJ; (2002) Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol , 107 (2) pp. 123-128. 10.1159/000046642.

GUPTA, R; Knight, CL; Bain, BJ; (2002) Receptor tyrosine kinase mutations in myeloid neoplasms. British Journal of Haematology , 117 (3) pp. 489-508.

Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica , 87 (2) pp. 167-176. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. HAEMATOLOGICA , 87 (2) 167 - 176. Gold open access

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gardiner, C; Mackie, IJ; Furrs, SA; Piegsa, K; Guillebaud, J; Machin, SJ; (2002) Acquired resistance to activated protein C is more pronounced in women receiving combined oral contraceptives containing desogestrel than levonorgestrel and is associated with low protein S levels. In: BLOOD. (pp. 113B - 113B). AMER SOC HEMATOLOGY

Gasco, M; Sullivan, A; Repellin, C; Brooks, L; Farrell, PJ; Tidy, JA; Dunne, B; ... Crook, T; + view all (2002) Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene , 21 (12) pp. 1876-1881. 10.1038/sj.onc.1205256.

Gentry, CC; Okolo, SO; Fong, LFWT; Crow, JC; MacLean, AB; Perrett, CW; (2002) Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. Clinical Science , 101 (6) pp. 691-695.

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; ... Mehta, AB; + view all (2002) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride (LY335979): In vitro data from a phase 1 trial. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 67A-67A). AMER SOC HEMATOLOGY

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; ... Mehta, AB; + view all (2002) Inhibition of P-gp activity in aml patients treated with zosuquidar trihydrochloride (LY335979): in vitro data from a phase 1 trial. BLOOD , 100 67a-.

Gibson, IR; Hing, KA; Revell, PA; Santos, JD; Best, SM; Bonfield, W; (2002) Enhanced in vivo response to silicate-substituted hydroxyapatite. UNSPECIFIED, London.

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, A-G; Calvez, V; ... Gazzard, B; + view all (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr , 31 (4) pp. 384-390.

Gore, M; Oza, A; Rustin, G; Malfetano, J; Calvert, H; Clarke-Pearson, D; Carmichael, J; ... Fields, SZ; + view all (2002) A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. EUR J CANCER , 38 (1) 57 - 63.

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Gemcitabine and carboplatin (GC) versus mitomycin, ifosfamide and cisplatin (MIP): a phase III randomised comparison in stage IIIb or IV non-small cell lung cancer (NSCLC). In: (pp. 399-).

Grasso, A; Quaglia, A; Montalto, P; Dhillon, AP; Patch, D; Davidson, B; Rolles, K; ... Burroughs, AK; + view all (2002) HCC and liver transplantation (LT): Risk factors for recurrence. In: J HEPATOL. (pp. 80 - 80). ELSEVIER SCIENCE BV

Gupta, N; Saleem, A; Osman, S; Hoskin, P; Price, PM; Aboagye, EO; (2002) Carbogen and nicotinamide selectively increase chemotherapy delivery and blood flow to liver metastasis. British Journal of Cancer , 86 S14-S14.

H

Hackshaw, AK; Wald, NJ; (2002) Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening. Prenatal Diagnosis , 22 pp. 1051-1055.

Hanawa, H; Kelly, PF; Nathwani, AC; Persons, DA; Vandergriff, JA; Hargrove, P; Vanin, EF; (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Molecular Therapy , 5 (3) pp. 242-251.

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A Phase I/II Study of CHARTWEL with concurrent chemotherapy in locally advanced inoperable carcinoma of the oesphagus. In: (pp. S27-).

Harney, J; Goodchild, K; Glynne-Jones, R; Phillips, H; Hoskin, PJ; Saunders, MI; (2002) A phase II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. In: (pp. 83-).

Harney, J; Shah, N; Joiner, M; Short, S; Saunders, MI; (2002) Low dose hyper-sensitivity- does it occur in normal skin? In:

Harney, J; Shah, N; Short, SC; Joiner, M; Saunders, MI; (2002) Low dose hyper-radiosensitivity - does it exist in normal skin? In: (pp. S57-).

Harney, J; Short, SC; Saunders, MI; (2002) Low dose hyper-radiosensitivity - A clinical assessment. In: (pp. S56-).

Harrison, CJ; Foroni, L; (2002) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology , 6 (2) pp. 91-113.

Harrison, CJ; Mazzullo, H; Ross, FM; Cheung, KL; Gerrard, G; Harewood, L; Mehta, A; ... Orchard, KH; + view all (2002) Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. BRIT J HAEMATOL , 117 (2) 427 - 435.

Harrison, CN; Donohoe, S; Carr, P; Dave, M; Mackie, I; Machin, SJ; (2002) Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. THROMB HAEMOSTASIS , 87 (5) 802 - 807.

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; Gregson, SJ; ... Thurston, DE; + view all (2002) In vitro antitumor activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: (pp. 2432-).

Hartley, JA; Spanswick, VJ; Pedley, RB; Hollingshead, MG; Alley, MC; Schultz, R; Gregson, SJ; ... D, E; + view all (2002) In vitro activity and in vivo DNA interstrand crosslinking by the novel pyrrolobenzodiazepine dimer SJG-136 (NSC 694501). In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 489-).

Heelan, BT; Tormey, V; Amlot, PL; Payne, E; Mehta, A; Webster, AD; (2002) Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology , 118 (4) pp. 1078-1081.

Hercus, B; Saeed, S; Revell, PA; (2002) Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med , 13 (12) pp. 1153-1156.

Hoskin, P; (2002) Secondary malignancies after radiotherapy. The Lancet Oncology , 3 (9) pp. 577-578.

Hoskin, PJ; (2002) Conformal radiotherapy to the prostate: are bigger fields better? Clinical Oncology , 14 (4) pp. 296-297.

Hoskin, PJ; (2002) FDG PET in the management of lymphoma: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging , 29 (4) pp. 449-451.

Hoskin, PJ; (2002) Tumour hypoxia and vascularity in lymphoma. In: (pp. 615-).

Hoskin, PJ; (2002) Radiotherapy in cancer pain management. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (pp. 253-258). : London.

Hoskin, PJ; (2002) Radiotherapy in palliative care. In: Rice, ASC and Warfield, CA and Justins, D and Eccleston, C and Arnold, E, (eds.) Clinical Pain Management. (pp. 281-292). Arnold: London.

Hoskin, PJ; Bownes, P; Summers, A; (2002) The influence of applicator angle on dosimetry in vaginal vault brachytherapy. British Journal of Radiology , 75 (891) pp. 234-237.

Hoskin, PJ; Grover, A; Bhana, R; (2002) Optimal radiotherapy dose for metastatic spinal canal compression. British Journal of Cancer , 86 S20-S20.

Hoskin, PJ; Morgan, DAL; Robinson, M; (2002) Erythropoetin supplementation for radical radiotherapy in head and neck cancer: an interim analysis of a randomized phase III trial. In: (pp. 83-).

Hoskin, PJ; Smith, P; Linch, DC; (2002) Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone. In: (pp. 215-).

Hough, RE; Welch, JC; Vora, AJ; (2002) Potency of the graft versus leukaemia (GVL) effect following unrelated donor cord blood (CB) transplant. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 407B-407B). AMER SOC HEMATOLOGY

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; McNulty, L; ... Lee, M; + view all (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso- cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco- cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. Bioorganic and Medicinal Chemistry , 10 (9) pp. 2941-2952.

Hsieh, JK; Yap, D; O'Connor, DJ; Fogal, V; Fallis, L; Chan, F; Zhong, S; (2002) Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Molecular and Cellular Biology , 22 (1) pp. 78-93.

Hughes, SE; (2002) Cardiac stem cells. The Journal of Pathology (197) pp. 468-478.

Hughes, SE; (2002) Heart muscle disease. Medicine (30) pp. 89-91.

Hughes, SE; (2002) Expression of the Fibrogrowth Factor (FgF and the Fibroblast Growth Factor Receptor (FGFR)Multigene Families in Normal and Atherosclerotic Human Arteries. In: Pedro, C, (ed.) Fibroblast Growth Factor in the Cardiovascular System. (pp. 117-131). I Holzapfel: Munich.

I

Imrie, KR; Linch, DC; Czuczman, MS; (2002) Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma. ANTI-CANCER DRUGS , 13 S19 - S24.

J

James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; Ellis, P; ... Spiro, SG; + view all (2002) A phase III randomised comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC. In: (pp. 1170-).

James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; Ellis, P; ... Spiro, SG; + view all (2002) A randomised phase III comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC). In: (pp. 399-).

James, R.D.; Maughan, T.S.; Kerr, D.J.; Ledermann, J.A.; McArdle, C.; Seymour, M.T.; Cohen, D.; ... Stephens, R.J.; + view all (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. The Lancet , 359 (9317) pp. 1555-1563. 10.1016/S0140-6736(02)08514-8.

Jarvis, M; Marzolini, M; Wang, X; Dickinson, A; (2002) Expression of heat shock protein 60 and 70 in a human in vitro skin explant model of acute graft versus host disease - Quantitative assessment using scanning laser confocal microscopy. In: (pp. S62-S62). NATURE PUBLISHING GROUP

Jennings, BH; (2002) Stopping Transcription in its Tracks. Nature Genetics , 32 pp. 87-88.

Jones, B; Aird, E; Colyer, H; Dobbs, J; Harris, R; Hoskin, P; McKenzie, A; (2002) United Kingdom Radiation Oncology 1 conference (UKRO 1): Accuracy and uncertainty in radiotherapy. BRITISH JOURNAL OF RADIOLOGY , 75 (892) pp. 297-306. 10.1259/bjr.75.892.750297.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access
file

K

Kenny, PA; Enver, T; Ashworth, A; (2002) Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC MOL BIOL , 3 , Article 13. 10.1186/1471-2199-3-13. Green open access
file

Keshtgar, MRS; Lee, AC; Pickard, CDP; Briggs, GM; Falzon, M; Bigio, IJ; Bown, SG; (2002) Optical biopsy: The technique and experience in determining lymph node status in breast cancer. In: (Proceedings) Sentinel Node. : Yokohama, Japan.

Khan, AW; Dhillon, AP; Hutchins, R; Abraham, A; Shah, SR; Snooks, S; Davidson, BR; (2002) Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , 28 (6) 637 - 644. 10.1053/ejso.2002.1307.

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) pp. 379-388.

Kirkby, N; Faraday, DBF; Short, S; C, W; M, J; M C, B; N, G; (2002) Mathematical modelling to develop a novel radiotherapy schedule for high grade brain tumours, based on phase distribution of low-dose hypersensitivity in human glioma cell lines. In:

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. JOURNAL OF GENE MEDICINE , 4 (6) pp. 592-600. 10.1002/jgm.306.

Kitajima, K; Masuhara, M; Era, T; Enver, T; Nakano, T; (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO JOURNAL , 21 (12) pp. 3060-3069. 10.1093/emboj/cdf301.

Kiuru, M; Barker, K; Launonen, V; Lu, YJ; Bevan, S; Herva, R; Arola, J; ... Houlston, R; + view all (2002) Role of the HLRCC/MCUL1 locus in development of leiomyosarcomas and renal cell cancer. British Journal of Cancer , 87 pp. 446-448.

Kocjan, G; (2002) Cytopathology of the thyroid. Current Diagnostic Pathology , 8 pp. 201-205.

Kocjan, G; (2002) Pitfalls in cytology of endocrine organs. CPD Bulletin Cellular Pathology , 4 pp. 21-29.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Gale, RE; Holt, M; Wheatley, K; Goldstone, AH; Burnett, AK; Linch, DC; (2002) Consolidation of AML therapy with autograft and allograft procedures does not negate the poor prognostic impact of FLT3 internal tandem duplications: Results from the UK MRC AML 10 and 12 trials. In: BLOOD. (pp. 75A - 75A). AMER SOC HEMATOLOGY

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; Demuynck, HM; ... Goldstone, AH; + view all (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kottke, TJ; Blajeski, AL; Meng, XW; Svingen, PA; Ruchaud, S; Mesner, PW; Boerner, SA; ... Kaufmann, SH; + view all (2002) Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. pp. 804-815. Gold open access

Kumar, S; Chandra, J; Grote, D; Cattaneo, R; Kaufmann, S; Fielding, A; (2002) Bcl-2 over-expression results in decreased measles virus mediated cytotoxicity in lymphoma cell lines. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 577A-578A). AMER SOC HEMATOLOGY

Kyriacou, CA; Goldstone, AH; Taghipour, G; Avivi, I; Kottaridis, PD; Dogan, A; Linch, DC; (2002) Patients with chemosensitive angioimmunoblastic lymphoma (AITL) can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 74 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 644A - 644A). AMER SOC HEMATOLOGY

L

Lagging, LM; Garcia, CE; Westin, J; Wejstal, R; Norkrans, G; Dhillon, AP; Lindh, M; (2002) Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J CLIN MICROBIOL , 40 (11) 4224 - 4229. 10.1128/JCM.40.11.4224-4229.2002.

Lakhani, SR; Flanagan, AM; (2002) Genetics, screening and management. In: Pathology of the breat and ovary in mutation carriers in familial breast and ovarian cancer. (pp. 108-124).

Lakhani, SR; Flanagan, AM; (2002) Pathology of the breast and ovary in mutation carriers in familial breast and ovarian cancer. In: Familial Breast and Ovarian Cancer: genetics, screening and management. (pp. 108-124). CUP: Cambridge.

Ledermann, JA; Herd, R; (2002) High-Dose Chemotherapy in Ovarian Cancer in High Dose Chemotherapy:. In: Lorrigan, P and Vandenberghe, E, (eds.) Principles and Practice. (pp. 143-156). Martin Dunitz

Lee, AC; Keshtgar, MRS; Pickard, CDP; Kocjan, G; Falzon, M; Bigio, IJ; Ell, PJ; (2002) Comparative study of imprint cytology and elastic scattering spectroscopy in assessing sentinel lymph node status in breast cancer. In: (Proceedings) Sentinel Node. : Yokohama, Japan.

Lee, AC; Pickard, CDO; Briggs, GM; Bigio, IJ; Falzon, M; Keshtgar, MRS; Bown, SG; (2002) Elastic scattering spectroscopy for intraoperative detection of sentinel lymph node metastasis. In: (pp. 79-).

Lee, AC; Pickard, CDO; Keshtgar, MRS; Briggs, GM; Falzon, M; Lakhani, S; Bigio, I; (2002) Elastic scattering spectroscopy for the diagnosis of breast cancer. In: BRIT J SURG. (pp. 74 - 74). JOHN WILEY & SONS LTD

Lee, AC; Pickard, CDO; Keshtgar, MRS; Briggs, GM; Falzon, M; Lakhani, S; Ell, PJ; ... Bown, SG; + view all (2002) Intraoperative assessment by optical biopsy for lymph node metastasis in breast cancer. In: BRIT J SURG. (pp. 640 - 641). JOHN WILEY & SONS LTD

Lee, SM; James, LE; Mohamed-Ali, V; Boschoff, C; Snee, M; Brock, C; Leary, A; ... Prendiville, J; + view all (2002) A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC). In: (Proceedings) Oral presentation. 2002 ASCO Annual Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1251-). Proceedings of the American Society of Clinical Oncology

Lee, Y.C.; Boehm, M.K.; Chester, K.A.; Begent, R.H.J.; Perkins, S.J.; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. Journal of Molecular Biology , 320 (1) pp. 107-127. 10.1016/S0022-2836(02)00403-5.

Lee, YC; Boehm, MK; Chester, KA; Begent, RHJ; Perkins, SJ; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J MOL BIOL , 320 (1) 107 - 127. 10.1016/S0022-2836(02)00403-5.

Leonard, P; Ledermann, JA; (2002) Gastrointestinal Oncology in Practical Gastroenterology. In: Bloom, S, (ed.) Practical Gastroenterology. (pp. 225-240). Martin Dunitz

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. BRIT J CANCER , 87 (11) 1216 - 1220. 10.1038/sj.bjc.6606641.

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. Br J Cancer , 87 (11) pp. 1216-1220. 10.1038/sj.bjc.6600641.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; Cunningham, D; ... UK Lymphoma Grp, ; + view all (2002) A randomised trial of CHOP x 6-8 vs CHOP x 3+BEAM + ASCT in 457 patients with poor prognosis histologically aggressive non-Hodgkins lymphoma. BRIT J CANCER , 86 S1 - S2.

Lu, X; Kuwabara, P; Selwood, D; (2002) P53 Binding Polypeptide. WO/2004/031229.

M

MacGregor, A; Hackshaw, A; (2002) Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements: A double-blind placebo controlled study. Journal of Family Planning and Reproductive Health Care , 28 (1) pp. 27-31.

Mackie, IJ; Lawrie, AS; Purdy, G; Williams, T; Machin, SJ; (2002) DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use. In: BLOOD. (pp. 88B - 89B). AMER SOC HEMATOLOGY

Makris, A; Burcombe, RJ; Wilson, GD; Richman, PI; Allen, S; Wright, D; Pittam, M; (2002) Comparison of clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy for primary breast cancer. European Journal of Cancer , 38 268-.

Manderson, EN; Presneau, N; Provencher, D; Mes-Masson, AM; Tonin, PN; (2002) Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. MOL CARCINOGEN , 34 (2) 78 - 90. 10.1002/mc.10051.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update August 2001. Tissue Antigens , 59 (1) pp. 73-74.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update September 2001. Tissue Antigens , 59 (1) pp. 75-76.

Marsh, SGE; (2002) Nomenclature for factors of the HLA System, update September 2001. Eur J Immunogenet , 29 (1) 79-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update April 2002. Eur J Immunogenet , 29 (5) pp. 457-458.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update December 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 117. 10.1046/j.1365-2370.2002.00317.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update February 2002. Eur J Immunogenet , 29 (3) 277-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update January 2002. Eur J Immunogenet , 29 (3) 275-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update June 2002. Eur J Immunogenet , 29 (5) 461-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update March 2002. Eur J Immunogenet , 29 (3) pp. 279-280.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update May 2002. Eur J Immunogenet , 29 (5) 459-.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (6) pp. 463-516. 10.1046/j.1365-2370.2002.00359.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 (5) pp. 407-464.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update December 2001. Tissue Antigens , 59 (2) pp. 172-173.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update November 2001. Tissue Antigens , 59 (2) pp. 170-171.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update October 2001. Tissue Antigens , 59 (2) pp. 168-169.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update April 2002. Hum Immunol , 63 (9) pp. 795-796.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Hum Immunol , 63 (6) 514-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Hum Immunol , 63 (6) pp. 515-516.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, updated May 2002. Hum Immunol , 63 (10) 966-.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Tissue Antigens , 59 (3) pp. 237-238.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update January 2002. Tissue Antigens , 59 (3) pp. 235-236.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Tissue Antigens , 59 (3) pp. 239-240.

Marzolini, MAV; Wynne, H; (2002) Should patients manage their own oral anticoagulation therapy? Reviews in Clinical Gerontology , 12 (4) pp. 275-281.

Mateos, A; Herrero, J; Dopazo, J; (2002) Using perceptrons for supervised classification of DNA microarray samples: Obtaining the optimal level of information and finding differentially expressed genes. In: Dorronsoro, JR, (ed.) (Proceedings) 12th International Conference on Artifical Neural Networks (ICANN 2002). (pp. pp. 577-582). SPRINGER-VERLAG BERLIN

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. British Journal of Cancer , 86 S117-S117.

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. BRIT J CANCER , 86 S117 - S117.

McHugh, PJ; Kiakos, K; Hartley, JA; Lee, M; (2002) The Rad6 pathway is involved in the nucleotide excision repair of DNA minor groove adducts. In: (pp. 5103-).

McIlhatton, BP; Keating, C; Curran, MD; McMullin, MF; Barr, JG; Madrigal, JA; Middleton, D; (2002) Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA). J MED MICROBIOL , 51 (6) pp. 468-478.

Mehta, A; (2002) Agalsidase alfa: specific treatment for Fabry disease. Hospital Medicine , 63 (6) pp. 347-350.

Mehta, A; (2002) New developments in the management of Anderson-Fabry disease. QJM , 95 pp. 647-653.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) pp. 118-119.

Mills, KI; Gilkes, AF; Linch, DC; Burnett, AK; (2002) Risk group stratification in AML by the use of micro-arrays. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

Monastiri, K; Ben Ahmed, S; Presneau, N; Bignon, JY; Chouchane, L; (2002) [Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families]. Tunis Med , 80 (9) pp. 515-518.

Mortuza, FY; Papaioannou, M; Moreira, IM; Coyle, LA; Gameiro, P; Gandini, D; Prentice, HG; ... Foroni, L; + view all (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology , 20 (4) pp. 1094-1104.

Mushipe, MT; Revell, PA; Shelton, JC; (2002) Cancellous bone repair using bovine trabecular bone matrix particulates. Biomaterials , 23 (2) pp. 365-370. 10.1016/S0142-9612(01)00114-4.

Mushipe, MT; Revell, PA; Shelton, JC; (2002) The effects of bovine trabecular bone matrix particulates on cortical bone repair. Journal of Materials Science: Materials in Medicine , 13 (1) pp. 99-105.

N

Nacheva, EP; Reid, AG; Tarpey, PS; Grace, CD; (2002) Quantification of locus copy number in chronic myeloid leukaemia using multiplex amplifiable probe hybridisation (MAPH). In: BLOOD. (pp. 325B - 325B). AMER SOC HEMATOLOGY

Nakahara, T; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2002) Effects of exposure of CHO-K1 cells to a 10-T static magnetic field. Radiology , 224 (3) pp. 817-822. 10.1148/radiol.2243011300.

Nash, M; Cohen, H; (2002) Disorders of thrombosis and haemostasis. Surgery , 30 pp. 203-208.

Nathwani, A; Davidoff, AM; Hanawa, H; Hu, Y; Hoffer, FA; Nikanorov, A; Slaughter, C; ... Nienhuis, AW; + view all (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood , 100 (5) pp. 1662-1669. 10.1182/blood-2002-02-0589. Green open access
file

Nicholson, PW; Harland, SJ; (2002) Survival prospects after screen-detection of prostate cancer. BJU INT , 90 (7) 686 - 693. 10.1046/j.1464-4096.2002.03005.x.

Nikitenko, LL; Smith, DM; Hague, S; Wilson, CR; Bicknell, R; Rees, MCP; (2002) Adrenomedullin and the microvasculature. TRENDS PHARMACOL SCI , 23 (3) 101 - 103.

Nnene, IO; Nieto, JJ; Rolfe, KJ; Crow, JC; Sundaresan, M; MacLean, AB; Perrett, CW; (2002) P53 expression in ovarian epithelial dysplasia. In:

O

Oakley, TJ; Goodwin, A; Chakraverty, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA Repair (Amst) , 1 (6) pp. 463-482.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; Hamoudi, R; ... Meignin, V; + view all (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) pp. 2331-2336.

Orchard, K; Barrington, S; Buscombe, J; Hilson, A; Prentice, HG; Mehta, A; (2002) Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. British Journal of Haematology , 117 (1) pp. 133-135.

P

Patel, K; Stein, R; Benvenuti, S; Zvelebil, MJ; (2002) Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identification. PROTEOMICS , 2 (10) pp. 1464-1473. 10.1002/1615-9861(200210)2:10<1464::AID-PROT1464>3.0.CO;2-9.

Patel, N; Best, SM; Bonfield, W; Gibson, IR; Hing, KA; Damien, E; Revell, PA; (2002) A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. Journal of Materials Science: Materials in Medicine , 13 (12) pp. 1199-1206.

Patel, N; Gibson, IR; Hing, KA; Best, SM; Damien, E; Revell, PA; Bonfield, W; (2002) The in vivo response of phase pure hydroxyapatite and carbonate substituted hydroxyapatite granules of varying size ranges. UNSPECIFIED

Patel, Y; Moraes, YC; Latchman, D; Coffin, R; de Belleroche, J; (2002) Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. MOL BRAIN RES , 109 (1-2) 189 - 197.

Payne, EM; Gerrard, G; Ganeshaguru, K; McCullough, H; Ethell, M; Potter, M; Prentice, HG; ... Mehta, AB; + view all (2002) A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 557A-557A). AMER SOC HEMATOLOGY

Pedley, RB; El-Emir, E; Flynn, AA; Boxer, GM; Dearling, J; Raleigh, JA; Hill, SA; ... Begent, RHJ; + view all (2002) Synergy between vascular targeting agents and antibody-directed therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 54 (5) 1524 - 1531.

Peggs, K; (2002) Donor lymphocyte infusion following reduced intensity allografting. In: BONE MARROW TRANSPLANTATION. (pp. S37 - S38). NATURE PUBLISHING GROUP

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; Danos, O; ... Apparailly, F; + view all (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) pp. 2161-2172. 10.1089/104303402320987851.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; ... Madrigal, JA; + view all (2002) Further polymorphism of the MICA gene. EUR J IMMUNOGEN , 29 (1) pp. 35-46.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, J; Boxer, GM; (2002) The spatial accuracy of 3D reconstructed radioluminographs on serial tissue sections and the resultant absorbed dose estimates. Physics in Medicine and Biology , 47 pp. 3651-3661.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; Boxer, GM; ... Begent, RHJ; + view all (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. Physics in Medicine and Biology , 47 (20) pp. 3651-3661. 10.1088/0031-9155/47/20/307.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; Boxer, GM; ... Begent, RHJ; + view all (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. PHYS MED BIOL , 47 (20) 3651 - 3661.

Pickard, D; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2002) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. OPTICAL BIOPSY IV , 4613 234 - 243.

Pietersen, AAM; Tolboom, TCA; Zhang, YH; van Dijk, L; Henriquez, NV; Noteborn, MHM; Huizinga, TWJ; (2002) Fibroblast-like synoviocytes from RA patients exploit a tumor-specific apoptosis pathway whereas synoviocytes from controls do not. In: ARTHRITIS AND RHEUMATISM. (pp. S137 - S137). WILEY-LISS

Pileri, SA; Ascani, S; Zinzani, PL; Gaidano, G; Piccioli, M; Rossi, M; Piccaluga, PP; ... Sabattini, E; + view all (2002) Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach. Haematologica , 87 (12) ECR40-. Gold open access

Pinto, M; (2002) Induction and rejoining of DNA double-strand breaks in human cells after exposure to ionising radiation: an experimental and modelling approach. Doctoral thesis , University of London. Green open access
file

Plummer, R; Ghielmini, M; Calvert, P; Voi, M; Renard, J; Gallant, G; Gupta, E; ... Sessa, C; + view all (2002) Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies. CLIN CANCER RES , 8 (9) 2788 - 2797.

Pule, M; Gullmann, C; Dennis, D; McMahon, C; Jeffers, M; Smith, OP; (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. British Journal of Haematology , 118 (4) pp. 991-998.

Pérez-Rodríguez, M; Argüello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; ... Madrigal, JA; + view all (2002) Further polymorphism of the MICA gene. European Journal of Immunogenetics , 29 (1) pp. 35-46. 10.1046/j.0960-7420.2001.00275.x.

Q

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; ... Dhillon, AP; + view all (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. In: J HEPATOL. (pp. 217 - 218). ELSEVIER SCIENCE BV

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; ... Dhillon, AP; + view all (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. Journal of Hepatology , 36 776-.

Quaglia, A; Laurent, C; Girlando, S; Saini, J; Dalla Palma, P; Colombari, R; Bioulac-Sage, P; ... Dhillon, AP; + view all (2002) Clonality and genomic heterogeneity in HCC and putative precursor nodular lesions. J HEPATOL , 36 83 - 83.

R

Ramon, D; Corell, A; Cox, ST; Soteriou, B; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (5) pp. 453-455. 10.1046/j.1365-2370.2002.00354.x.

Reid, AG; Huntly, BJP; Hennig, E; Niederwieser, D; Campbell, LJ; Bown, N; Telford, N; ... Nacheva, EP; + view all (2002) Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. In: BLOOD. (pp. 2274 - 2275). AMER SOC HEMATOLOGY

Rew, SB; Lopes, L; Peggs, K; Koishihara, Y; Kosaka, M; Ozaki, S; Chain, B; (2002) Generation of T-cell mediated immune responses to the myeloma antigen, HM1.24. In: BLOOD. (pp. 105A - 105A). AMER SOC HEMATOLOGY

Rolfe, KJ; Crow, JC; Reid, WMN; Benjamin, E; MacLean, AB; Perrett, CW; (2002) The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus. BRIT J DERMATOL , 147 (3) 503 - 508.

Rooney, CM; Bollard, C; Huls, MH; Gahn, B; Gottschalk, S; Wagner, HJ; Anderson, R; ... Heslop, HE; + view all (2002) Immunotherapy for Hodgkin's disease. Annals of Hematology , 81 S39-S42.

Rowntree, C; Duke, V; Panayiotidis, P; Kotsi, P; Palmisano, GL; Hoffbrand, AV; Foroni, L; (2002) Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. LEUKEMIA , 16 (7) pp. 1267-1275. 10.1038/sj.leu.2402551.

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC). In: (pp. 1164-).

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; et, A; (2002) A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer. In: (Proceedings) Oral presentation. 2002 Annual ASCO Meeting/38th Annual Meeting, Orlando, FL.. (pp. 1164-). Proceedings of the American Society of Clinical Oncology

Rudnicka, AR; Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. PRENATAL DIAG , 22 (10) 893 - 897. 10.1002/pd.440.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; Yee, TT; ... Lee, CA; + view all (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Salomoni, P; Pandolfi, PP; (2002) p53 de-ubiquitination: at the edge between life and death. NAT CELL BIOL , 4 (6) E152 - E153. 10.1038/ncb0602-e152.

Saunders, MI; (2002) Chart and chemotherapy. Clinical Oncology , 14 (4) pp. 331-332.

Schellens, JHM; Heinrich, B; Lehnert, M; Gore, ME; Kaye, SB; Dombernowsky, P; Paridaens, R; ... Hanauske, AR; + view all (2002) Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies. INVEST NEW DRUG , 20 (1) 83 - 93.

Schmitz, N; Pfistner, B; Sextro, M; Sieber, M; Carella, AM; Haenel, M; Boissevain, F; ... Diehl, V; + view all (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. The Lancet , 359 (9323) pp. 2065-2071. 10.1016/S0140-6736(02)08938-9.

Sepulveda, CAG; Robinson, J; Schilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2002) Characterisation of the KIR genes in HLA homozygolis cell lines. TISSUE ANTIGENS , 59 pp. 9-10.

Serra, J; Sales, M; Chitolie, A; Domenech, P; Rossi, E; Borrell, M; Dahlback, B; (2002) Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S. THROMB HAEMOSTASIS , 88 (6) 975 - 983.

Shams, PN; Waldman, A; Dogan, A; MacKenzie, JM; Plant, GT; (2002) Ataxia in the setting of complicated enteropathy: double jeopardy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 72 (4) pp. 527-529.

Sharma, SK; Pedley, RB; Bhatia, J; Irwin, HL; El-Emir, E; Boxer, GM; Boden, RW; ... R, HJ; + view all (2002) Antibody-directed enzyme prodrug therapy (ADEPT): comparison in two colorectal carcinoma xenografts. In: (Proceedings) proceedings AmericanAssociation for Cancer Research. (pp. 943-).

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clinical and Laboratory Haematology , 24 pp. 1-3.

Shaw, BE; Marsh, SGE; Mayor, NP; Prentice, HG; Pay, AL; Little, AM; Potter, MN; (2002) Donor age is not a significant factor affecting overall survival in HLA matched unrelated donor stem cell transplants. TISSUE ANTIGENS , 59 90 - 91.

Shaw, BE; Pay, AL; Potter, MN; Mayor, N; Prentice, HG; Little, AM; Marsh, SGE; (2002) HLA-DPB1 plays a role in the outcome of unrelated stem cell transplants in pairs completely matched at the other five transplantation loci. BONE MARROW TRANSPL , 29 S25 - S25.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Marsh, SGE; Madrigal, JA; (2002) Mild acute graft versus host disease improves overall survival in well matched T cell depleted unrelated donor transplants. TISSUE ANTIGENS , 59 124 - 124.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Travers, P; Marsh, SGE; (2002) Factors implicated in disease relapse following volunteer donor unrelated stem cell transplantation. TISSUE ANTIGENS , 59 125 - 125.

Short, KA; GROVES, RW; Novelli, MR; (2002) Haemorrhage into chronic plaque psoriasis as a consequence of disseminated intravascular coagulation. Clinical and Experimental Dermatology , 27 (6) pp. 471-473.

Short, SC; Harney, J; Dopson, F; Saunders, MI; (2002) The effects of low-dose fractionated radiation on sarcomas- experimental and clinical data. British Journal of Cancer , 86 S56-S57.

Sibtain, A; Hill, S; Goodchild, K; Shah, N; Saunders, M; Hoskin, PJ; (2002) The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. Radiotherapy And Oncology , 62 (1) pp. 69-76.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2002) Hypoxia in bladder cancer: Validation of intrinsic markers with pimonidazole and their influence on clinical outcome after accelerated radiotherapy with carbogen and nicotinamide. British Journal of Cancer , 86 S28-S29.

Sinclair, AM; Bench, AJ; Bloor, AJC; Gottgens, JLB; Stanley, ML; Miller, J; Piltz, S; ... Green, AR; + view all (2002) Rescue of the lethal scl(-/-) phenotype by the human SCL locus. BLOOD , 99 (11) 3931 - 3938.

Southworth, R; Dearling, J; Medina, R; Flynn, A; Pedley, RBAG; P, ; (2002) 18FDG and 14C DG6P accumulation differ in the isolated heart: an autoradiographic study. In: (pp. 59-).

Southworth, R; Dearling, JLJ; Medina, RA; Flynn, AA; Pedley, RB; Garlick, PB; (2002) Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique. EUR J NUCL MED MOL I , 29 (10) 1334 - 1341. 10.1007/s00259-002-0922-2.

Spalding, DRC; Hochhauser, D; Hartley, J; Davidson, B; (2002) Heterogeneity of response to chemotherapy in liver tumours evaluated by the comet assay in an isolated perfused human liver. British Journal Of Surgery , 89 p. 50.

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; Hochhauser, D; (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access
file

Spencer, DIR; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; Sharma, SK; ... Chester, KA; + view all (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. PROTEOMICS , 2 (3) 271 - 279.

Spender, LC; Cornish, GH; Sullivan, A; Farrell, PJ; (2002) Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J Virol , 76 (10) pp. 4919-4927.

Standish, R; Dhillon, A; Gibson, A; Jenkins, J; Difford, J; Savage, K; Atkins, M; ... Dhillon, A; + view all (2002) The assessment of fibrosis in liver biopsies from patients with chronic HBV infection - Image analysis vs Ishak stage score. Journal of Hepatology , 36 986-.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; Mackie, I; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: A source of the plasma form of prion protein? British Journal of Haematology , 119 (3) pp. 863-873. 10.1046/j.1365-2141.2002.03847.x.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; Mackie, I; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? BRIT J HAEMATOL , 119 (3) 863 - 873.

Steele, JPC; Shamash, J; Barlow, CS; Evans, MT; Gower, NH; Rudd, RM; (2002) Phase II trial of irinotecan, cisplatin and mitomycin C (IPM) in malignant pleural mesothelioma. In: (pp. 1227-).

Stephens, RJ; Brown, JM; Fairlamb, DJ; Gower, N; Maslove, L; Milroy, R; Napp, V; ... Waller, D; + view all (2002) The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting. British Journal of Cancer , 86 S2-S2.

Stephens, RJ; Fairlamb, DJ; Gower, NH; Maslove, L; Milroy, R; Napp, V; Peake, MD; ... Waller, D; + view all (2002) The Big Lung Trial (BLT): determining the value of cisplatin based chemotherapy for all patients with non-small cell lung cancer (NSCLC). In: (pp. 1161-).

Stephens, RJ; Gower, NH; Napp, V; Rudd, RM; Spiro, SG; Thorpe, H; (2002) On behalf of the BLT Steering Committee and Participants: The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). In: (pp. 399-).

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; Watson, S; (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. GASTROENTEROLOGY , 122 (4) A380 - A380.

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; Watson, SA; (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. Gut , 50 139-.

Sullivan, A; Yuille, M; Repellin, C; Reddy, A; Reelfs, O; Bell, A; Dunne, B; ... Crook, T; + view all (2002) Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene , 21 (9) pp. 1316-1324. 10.1038/sj.onc.1205207.

Szekely, Z; Kosakowska-Cholody, T; Hartley, JA; Michejda, CJ; (2002) Coupling minor groove binders with intercalators, an attempt to design chemical gene knockout agents. In: (pp. 2428-).

T

Tamames, J; Clark, D; Herrero, J; Dopazo, J; Blaschke, C; Fernandez, JM; Oliveros, JC; (2002) Bioinformatics methods for the analysis of expression arrays: data clustering and information extraction. JOURNAL OF BIOTECHNOLOGY , 98 (2-3) pp. 269-283. 10.1016/S0168-1656(02)00137-2.

Thiselton, DL; Alexander, C; Taanman, JW; Brooks, SP; Rosenberg, T; Eiberg, H; Andreasson, S; ... Votruba, M; + view all (2002) A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci , 43 (6) pp. 1715-1724.

Thomas, HD; Porter, DJ; Bartelink, I; Nobbs, JR; Cole, M; Elliott, S; Newell, DR; ... Boddy, AV; + view all (2002) Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide. BRIT J CLIN PHARMACO , 53 (1) 83 - 91.

Thomas, R; Makris, A; Bloomfield, D; Godward, S; Moody, M; (2002) Empowering patients to make informed treatment decisions based on tolerability, quality of life patient preference. A comparison of letrozole and anastrazole in a multicentre, randomised, single-blind cross over study. European Journal of Cancer , 38 171-.

Tiercy, JM; Marsh, SGE; Schreuder, GMTH; Albert, E; Fischer, G; Wassmuth, R; (2002) Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. European Journal of Immunogenetics , 29 pp. 273-274.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; Bowen, JP; ... Lee, M; + view all (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. BIOORG MED CHEM LETT , 12 (16) 2245 - 2248.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; Bowen, JP; ... Lee, M; + view all (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. Bioorg Med Chem Lett , 12 (16) pp. 2245-2248.

Trent, S; Kong, A; Short, SC; Traish, D; Ashley, S; Dowe, A; Hines, F; (2002) Temozolomide as second-line chemotherapy for relapsed gliomas. Journal of Neuro-Oncology , 57 (3) pp. 247-251.

Tsuzuki, S; Enver, T; (2002) Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein. BLOOD , 99 (9) pp. 3404-3410. 10.1182/blood.V99.9.3404.

Tsuzuki, S; Enver, T; Zelent, A; (2002) Ligand dependent potentiation of GATA-2 activity through interaction with retinoic acid receptors. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 718A-718A). AMER SOC HEMATOLOGY

U

UCL, AR; (2002) Achievements: UCL's academics conducted pioneering work at the forefront of their disciplines during this year. pp. 12-13.

UCL, PS; (2002) Thalidomide to be used in cancer fight. 44-.

V

Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2002) Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. CANCER RESEARCH , 62 (14) pp. 4095-4099.

Venables, K; Winfield, E; Aird, E; Hoskin, PJ; (2002) Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 pp. 271-279.

Vinall, LE; King, M; Novelli, M; Green, CA; Daniels, G; Hilkens, J; Sarner, M; (2002) Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology , 123 (1) pp. 41-49.

W

Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Antenatal screening policies for Down's syndrome - Audit of Down's syndrome screening is not valid. BRIT MED J , 325 (7371) 1034 - 1034.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Linch, DC; (2002) Isolex 300i and CliniMACS clinical scale CD34 selection devices: A split harvest comparison. LEUKEMIA , 16 (3) 416 - 416.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: A direct comparison of the CliniMACS® (v2.1) and Isolex® 300i (v2.5) clinical scale devices. British Journal of Haematology , 118 (1) pp. 117-123. 10.1046/j.1365-2141.2002.03561.x.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol , 118 (1) pp. 117-123.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS((R)) (v2 center dot 1) and Isolex((R)) 300i (v2 center dot 5) clinical scale devices. BRIT J HAEMATOL , 118 (1) 117 - 123.

Winfield, E; Deighton, A; Venables, K; Hoskin, PJ; Aird, EGA; (2002) Survey of UK breast radiotherapy techniques: Background prior to the introduction of the quality assurance programme for the START (Standardisation of Radiotherapy) Trial in breast cancer. Clinical Oncology , 14 (4) pp. 267-271.

Winstanley, AM; Sandison, A; Bott, SR; Dogan, A; Parkinson, MC; (2002) Incidental findings in lymphadenectomy at radical prostatectomy. Journal of Clinical Pathology , 55 pp. 623-626.

Wong, LF; Fong, T; Siddiqui, GK; Gammell, SJ; Kini, M; Crow, JC; Bamberger, ES; ... Perrett, CW; + view all (2002) Quantification of angiogenesis in primary and metastatic epithelial ovarian carcinomas. BRIT J CANCER , 86 S45 - S45.

Wong, WL; Campbell, H; Saunders, M; (2002) Positron emission tomography (PET) - Evaluation of 'indeterminate pulmonary lesions'. Clinical Oncology , 14 (2) pp. 123-128.

Woo, YL; Allard, S; Cohen, H; Letsky, E; de Swiet, M; (2002) Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG-INT J OBSTET GY , 109 (4) 466 - 468.

Wotherspoon, AC; Dogan, A; Du, MQ; (2002) MALT lymphoma. Current Opinion in Hematology , 9 pp. 50-55.

Y

Yee, TT; Griffioen, A; Subel, B; Dusheiko, G; Patch, D; Lee, CA; (2002) HCV treatment in a cohort of patients with inherited bleeding disorders. In: ANTIVIRAL THERAPY. (pp. L125 - L126). INT MEDICAL PRESS LTD

Z

Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 296 (1) pp. 178-181. 10.1016/S0006-291X(02)00744-1.

Ziegler, A; Beck, S; Ehlers, A; Younger, R; Volz, A; (2002) Testicular transcripts of HLA-linked olfactory receptor genes exhibit exon sharing and extensive long-distance alternative splicing. TISSUE ANTIGENS , 59 39 - 40.

This list was generated on Sun Jun 17 02:30:02 2018 BST.